ROIV

#566
Roivant Sciences Ltd. - Common Shares
30.3 2 USD
+1.47%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
29.94
30.42
Intervallo Annuale
0.29
32.79
Variazione giornaliera
+1.47%
Variazione Mensile
+8.71%
Variazione di 6 mesi
+48.05%
Variazione Annuale
+65.59%
Chiusura Precedente
29.8 8
Open
30.3 3
Minimo
29.9 4
High
30.4 2
Volume
673
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 21.81 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-51.3
Rapporto prezzo/fatturato
2 326.88

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Notizie